Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-26

Clinical Trial Update: Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated neoadjuvant chemotherapy with optional addition of capecitabine and/or trastuzumab before surgery in women with stage I–III breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED